CEACAM1 protects the liver from MASLD and MASH by maintaining normal hepatic insulin clearance, reducing excessive FASN-induced hepatic fat accumulation and inflammation. The gene discussed is CEACAM1; the disease is metabolic dysfunction-associated steatohepatitis.